Skip to content
Search

Latest Stories

2023 was the highest year on record for NHS cancer checks

2023 was the highest year on record for NHS cancer checks

There has been a 133% increase in the number of people getting checked for cancer over the last decade.

NHS England delivered a record number of cancer checks last year, with almost three million people tested for the disease, according to official data published on Monday.


The heath service conducted 2,980,258 urgent cancer checks over the last 12 months (from November 2022 to October 2023).

Declared the highest year on record, this is 147,960 more than the number recorded on the same period last year.

With 269,492 urgent referrals, October 2023 was the highest month on record for cancer checks, the latest monthly figures showed.

In the same month, 192,889 people (more than 7 in 10) received all clear or a definitive diagnosis for cancer within one month.

Further, the NHS data showed a 133 per cent increase in the number of people getting checked for cancer in the decade since 2013. There were 1,275,231 urgent cancer referrals between Nov 2012 to Oct 2013.

Close to 60 per cent of cancers were diagnosed at stage one or two between September 2022 and August 2023, up by over two per cent from the number before the pandemic.

Dame Cally Palmer, National Cancer Director for NHS England, said: “More people than ever before have received potentially lifesaving checks for cancer over the last year, which is a testament to the hard work of NHS staff who have delivered this level of care, despite an extremely challenging year and unprecedented industrial action.

“We know there is more to do, but we have been throwing everything we have at catching cancers earlier because we know it’s the best way to save lives – and we are seeing progress with more people than ever before being diagnosed at stage one and two.

“With teams taking tests and checks closer to people who need them, and new treatments being made available all the time, we will continue to do all we can to get people seen and treated for cancer as early as possible.”

The NHS is targeting to diagnose three quarters of cancers at stage one or two when they are easier to treat.

Its lung health check programme to catch cancers earlier is considered a huge success, with almost 3,000 people with lung cancer being diagnosed so far, three quarters at stage one or two.

As part of this programme, mobile trucks go into the heart of communities to offer cancer checks at shopping centres and supermarket car parks.

To raise awareness about cancer signs and symptoms and encourage people to come forward for checks, the NHS has also put awareness messages on urinal mats in public toilets, underwear in Morrisons supermarkets, on a large double-decker bus travelling to cancer hot spots around the country.

Professor Peter Johnson, NHS England National Clinical Director for Cancer, commented: “Every year we are seeing extraordinary advances in treatment and new technologies coming through for patients, and I know this year will be no different.

“Cancer detected at an early stage gives people a much better chance of successful treatment, which is why the NHS has kept such a focus on early diagnosis and continues to find innovative ways to reach and test people in the community.

“Talking about cancer helps save lives too, so if you’re seeing friends and loved ones this new year, please check in with them and have a conversation, and if anyone is worried they might have signs or symptoms of cancer, please encourage them to get checked – the NHS is here for people and wants to see them at the earliest opportunity.”

The NHS has set out plans to eliminate cervical cancer by 2040 and save thousands of lives every year, by increasing HPV vaccine and screening uptake.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less